Leo Smit, Hy2Care – CartRevive® | LSI Asia '25

Hy2Care is a clinical phase company pursuing a breakthrough therapy with its CartRevive® hydrogel implant. The company’s vision is to support patients in the fight against osteoarthritis. Its lead product, CartRevive, is a hydrogel implant composed of dextran and hyaluronic acid conjugates that form a resorbable scaffold when injected. The hydrogel enables natural restoration of tissue defects by creating an environment conducive to cell regrowth that proceeds towards the restoration of smooth hyaline cartilage.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach